Search alternatives:
significantly improved » significantly increased (Expand Search)
significant changes » significant challenge (Expand Search)
improved decrease » improved urease (Expand Search), marked decrease (Expand Search)
changes decrease » larger decrease (Expand Search), largest decrease (Expand Search), change increases (Expand Search)
significantly improved » significantly increased (Expand Search)
significant changes » significant challenge (Expand Search)
improved decrease » improved urease (Expand Search), marked decrease (Expand Search)
changes decrease » larger decrease (Expand Search), largest decrease (Expand Search), change increases (Expand Search)
-
1
-
2
-
3
-
4
-
5
Significant associations in GWAS.
Published 2025“…These significant associations could be explained by the change in downstream NO signaling, supporting the relationship between the investigated traits and vascular function. …”
-
6
-
7
-
8
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
9
-
10
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
11
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
12
eQTL analysis of significant SNPs.
Published 2025“…These significant associations could be explained by the change in downstream NO signaling, supporting the relationship between the investigated traits and vascular function. …”
-
13
-
14
-
15
-
16
-
17
-
18
Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
-
19
Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
-
20
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”